all - Opinion Summaries
Page 7 of 88
Showing Result 61 - 70 of 874
| Description | Date | Docket # |
|---|---|---|
Novartis AG . v. Torrent Pharms. Ltd.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an appeal from the Final Written Decision of the United States Patent and Trademark Office, Patent Trial and Appeal Board in two consolidated inter... |
04/12/2017 | 2016-1352 |
The Medecines Co. v. Mylan, Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn a suit filed in response to an Abbreviated New Drug Application (ANDA) submitted by defendant, involving patents directed to pharmaceutical... |
04/06/2017 | 2015-1113, 2015-1151, 2015-1181 |
Novartis AG v. Noven Pharms., Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an appeal of inter partes review of pharmaceutical patents, the Patent Trial and Appeal Board's findings that various claims of the Patents-in-Suit... |
04/04/2017 | 2016-1678, 2016-1679 |
In Re: Fosamax Products Liability Litig.United States Third Circuit
Health Law, Injury & Tort Law, Drugs & Biotech, Product LiabilityIn consolidated personal-injury suits against a drug manufacturer, averring that the osteoporosis drug Fosamax caused plaintiffs to suffer serious... |
03/22/2017 | 14-1900 |
McClain v. Sav-On DrugsCalifornia Court of Appeal
Tax Law, Drugs & BiotechIn a class action suit filed by a group of customers predicated on their ability to obtain an order compelling the retail pharmacies to file an... |
03/13/2017 | B265011 |
Life Technologies Corp. v. Promega Corp.United States Supreme Court
Intellectual Property, Patent, Drugs & BiotechIn an infringement suit in which plaintiff sublicensed a patent, which claims a toolkit for genetic testing, for the manufacture and sale of the kits... |
02/22/2017 | 14-1538 |
Shire Development, LLC v. Watson Pharms., Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn a suit alleging defendant's infringement by filing an Abbreviated New Drug Application (ANDA) with the Food and Drug Administration seeking to... |
02/10/2017 | 2016-1785 |
Booker v. Pfizer, Inc.United States First Circuit
Health Law, Injury & Tort Law, Drugs & BiotechIn a qui tam action against a pharmaceutical defendant in federal district court, on behalf of the U.S., more than two dozen individual states, and... |
01/30/2017 | 16-1805 |
Cumberland Pharms. Inc. v. Mylan Institutional LLCUnited States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn an infringement involving a patent which describes and claims acetylcysteine compositions substantially free of chelating agents, the district... |
01/26/2017 | 2016-1155, 2016-1259 |
Eli Lily and Co. v. Teva Parenteral Medicines, Inc.United States Federal Circuit
Intellectual Property, Patent, Drugs & BiotechIn a consolidated Hatch-Waxman suit to prevent Defendants from launching a generic version of a chemotherapy drug with accompanying product literature... |
01/12/2017 | 2015-2067 |
Results 61 to 70 of 874